Clinical • PD(L)-1 Biomarker
|
BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog) • TRIM33 (Tripartite Motif Containing 33) • AGK (Acylglycerol Kinase)
|
BRAF mutation • NRAS mutation • BRAF fusion • AGK-BRAF fusion • NRAS mutation + BRAF mutation • RAF1 amplification
|
Keytruda (pembrolizumab) • Opdivo (nivolumab) • Yervoy (ipilimumab) • Ojemda (tovorafenib)